Showing 22,227 results

Filters Content type: Editors' picks
Condoms & lubricant

The Female Health Company to Expand Manufacturing Capacity for FC2 Female Condoms

Editor's pick
MarketWatch (press release)
23 April 2012
The search for an HIV prevention vaccine

Shingles vaccine is safe, according to new study

Editor's pick
Eurekalert Medicine & Health
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
HIV & criminal law

Is Criminalization of HIV Transmission Effective? Swedish Case Reveals Why the Why the Answer is No

Editor's pick
RH Reality Check
23 April 2012
PrEP

The 100 Most Influential People in the World: Robert Grant

Editor's pick
Time
23 April 2012
Access to healthcare

Kenya: UNAIDS welcomes High Court judgment on anti-counterfeit law

Editor's pick
UNAIDS
20 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Medivir Hep C Drug Cures 80% of Patients Post-Treatment

Editor's pick
Bloomberg BusinessWeek
20 April 2012
New & experimental hepatitis C treatment

Investigational Compound Peginterferon Lambda Achieved SVR24 Rates Comparable to Peginterferon Alfa with Fewer Flu-Like and Musculoskeletal Symptoms in Phase IIb Study in Treatment-Naive Genotype 2 or 3 Hepatitis C Patients

Editor's pick
BMS press release
20 April 2012
New & experimental hepatitis C treatment

Gilead’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol hepatitis C trial data impresses

Editor's pick
Reuters
20 April 2012
Global health initiatives

Can the Global Fund's new management change its fortunes?

Editor's pick
The Guardian
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol-Myers Squibb Put Profits Ahead of Best Care for Hep C Patients

Editor's pick
The Street
20 April 2012
Money

UK: NAT launches new report on HIV social care spending and services

Editor's pick
NAT press release
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
Global health initiatives

US Reveals Nearly $1.5 Billion in Unspent AIDS Money

Editor's pick
Global Post
19 April 2012
HIV prevention policy

US National Institutes of Health under fire for grants toward creation of homoerotic website

Editor's pick
Fox News
19 April 2012